High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$21.1M
$21,117,105
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
IONS
S
IONIS PHARMACEUTICALS INC
HOUGEN ELIZABETH L
• CFO
10b5-1 SellΔOwn -11.0%
2026-03-17
$744,662
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
CFO
10b5-1 SellΔOwn -11.0%
|
2026-03-17 | $744,662 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CFO
Other
|
2026-03-16 | $3,465,908Large | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CFO
Other
|
2026-03-16 | $1,079,647Large | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CFO
Other
|
2026-03-16 | $771,931 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
HOUGEN ELIZABETH L
• CFO
10b5-1 SellΔOwn -66.8%
2026-03-16
$14,882,113MEGA
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
CFO
10b5-1 SellΔOwn -66.8%
|
2026-03-16 | $14,882,113MEGA | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CFO
10b5-1 Sell
|
2026-03-16 | $686,902 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CFO
Other
|
2026-03-16 | $3,671,606Large | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CFO
Discretionary Sell
|
2026-01-30 | $581,702 | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CFO
Sell to Cover
|
2026-01-16 | $971,993 | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
HOUGEN ELIZABETH L
• CFO
10b5-1 SellΔOwn -31.1%
2025-09-30
$3,249,734Large
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
CFO
10b5-1 SellΔOwn -31.1%
|
2025-09-30 | $3,249,734Large | S | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
CFO
Other
|
2025-09-30 | $2,677,746Large | M | Form 4 |